Clonal hematopoiesis in human aging and disease
暂无分享,去创建一个
[1] J. Grimsby,et al. RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues , 2019, Science.
[2] L. Bullinger,et al. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] S. Tsunoda,et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers , 2019, Nature.
[4] B. Brüne,et al. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure , 2018, JAMA cardiology.
[5] S. Jaiswal,et al. Clonal hematopoiesis: Pre‐cancer PLUS , 2019, Advances in cancer research.
[6] Peter J. Campbell,et al. Somatic mutant clones colonize the human esophagus with age , 2018, Science.
[7] A. Tall,et al. Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2V617F Mice , 2018, Circulation research.
[8] P. A. Futreal,et al. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy , 2018, Cell stem cell.
[9] S. Fröhling,et al. MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML. , 2018, Blood.
[10] S. Carr,et al. PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells. , 2018, Blood.
[11] Peter J. Campbell,et al. Population dynamics of normal human blood inferred from somatic mutations , 2018, Nature.
[12] Stanley W. K. Ng,et al. Prediction of acute myeloid leukaemia risk in healthy individuals , 2018, Nature.
[13] S. Kathiresan,et al. Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis , 2018, Circulation. Genomic and precision medicine.
[14] Fei Lan,et al. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer , 2018, Nature.
[15] K. Ballman,et al. Somatic mutations precede acute myeloid leukemia years before diagnosis , 2018, Nature Medicine.
[16] Tyler J. Reich,et al. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells , 2018, Nature.
[17] Yakir A Reshef,et al. Insights about clonal hematopoiesis from 8,342 mosaic chromosomal alterations , 2018, Nature.
[18] K. Walsh,et al. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease , 2018, Circulation research.
[19] Vu Dinh,et al. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host , 2018, Nature.
[20] S. Mccarroll,et al. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms , 2018, Science Translational Medicine.
[21] Steve Horvath,et al. DNA methylation-based biomarkers and the epigenetic clock theory of ageing , 2018, Nature Reviews Genetics.
[22] D. Goukassian,et al. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. , 2018, Journal of the American College of Cardiology.
[23] R. Levine,et al. Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies. , 2018, Cell stem cell.
[24] R. Wells,et al. Tet2 restrains inflammatory gene expression in macrophages. , 2017, Experimental hematology.
[25] Traci M. Blonquist,et al. Risk and timing of cardiovascular death among patients with myelodysplastic syndromes. , 2017, Blood advances.
[26] D. Dunson,et al. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma , 2017, Cell.
[27] M. Ladanyi,et al. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. , 2017, Cell stem cell.
[28] Christopher A. Miller,et al. Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies. , 2017, The Journal of clinical investigation.
[29] Kari Stefansson,et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. , 2017, Blood.
[30] M. Dubé,et al. DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. , 2017, Blood.
[31] James M. Eales,et al. Loss of Y Chromosome in Blood Is Associated With Major Cardiovascular Events During Follow-Up in Men After Carotid Endarterectomy , 2017, Circulation. Cardiovascular genetics.
[32] Christian Gilissen,et al. Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life. , 2017, American journal of human genetics.
[33] S. Gabriel,et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.
[34] Matthew A. Cooper,et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.
[35] D. Neuberg,et al. Prognostic Mutations in Myelodysplastic Syndrome after Stem‐Cell Transplantation , 2017, The New England journal of medicine.
[36] C. Balestrieri,et al. Dnmt3a restrains mast cell inflammatory responses , 2017, Proceedings of the National Academy of Sciences.
[37] A. LaCasce,et al. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] Erika J. Thompson,et al. Pre-leukemic clonal hematopoiesis and the risk of therapy-related myeloid neoplasms: a case-control study , 2016, The Lancet. Oncology.
[39] B. Ebert,et al. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia , 2016, Nature Reviews Cancer.
[40] H. McLeod,et al. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study. , 2017, The Lancet. Oncology.
[41] Francine E. Garrett-Bakelman,et al. DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling , 2016, Nature Medicine.
[42] Hans Clevers,et al. Tissue-specific mutation accumulation in human adult stem cells during life , 2016, Nature.
[43] Michelle C. Chen,et al. Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation. , 2016, Cancer cell.
[44] Nicholas Eriksson,et al. Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. , 2016, Blood.
[45] T. Druley,et al. Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults , 2016, Nature Communications.
[46] Arthur P. Grollman,et al. Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing , 2016, Proceedings of the National Academy of Sciences.
[47] M. McVey,et al. Error‐Prone Repair of DNA Double‐Strand Breaks , 2016, Journal of cellular physiology.
[48] P. Campbell,et al. Somatic mutation in cancer and normal cells , 2015, Science.
[49] Xia Li,et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 , 2015, Nature.
[50] B. Ebert,et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.
[51] S. Miyano,et al. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. , 2015, The New England journal of medicine.
[52] M. Stratton,et al. High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.
[53] R. Fulton,et al. Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo. , 2015, Cancer cell.
[54] H. Deeg,et al. SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition. , 2015, Cancer cell.
[55] E. Zeggini,et al. Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis , 2015, Cell reports.
[56] D. Schübeler. Function and information content of DNA methylation , 2015, Nature.
[57] B. Vogelstein,et al. Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.
[58] Christopher A. Miller,et al. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation. , 2014, Blood.
[59] Christopher A. Miller,et al. The Role of TP53 Mutations in the Origin and Evolution of Therapy-Related AML , 2014, Nature.
[60] M. McCarthy,et al. Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.
[61] S. Gabriel,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.
[62] R. Brodsky,et al. Paroxysmal nocturnal hemoglobinuria. , 2014, Blood.
[63] Joshua F. McMichael,et al. Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.
[64] I. Weissman,et al. Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. , 2014, Cell stem cell.
[65] C. Franceschi,et al. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[66] Lincoln D. Stein,et al. Identification of pre-leukemic hematopoietic stem cells in acute leukemia , 2014, Nature.
[67] I. Weissman,et al. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission , 2014, Proceedings of the National Academy of Sciences.
[68] J. D. Fitzpatrick,et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. , 2013, The New England journal of medicine.
[69] M. Stratton,et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. , 2013, Blood.
[70] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[71] E. Riboli,et al. Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications , 2013, Nature Genetics.
[72] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[73] Mithat Gonen,et al. Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.
[74] I. Weissman,et al. Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia , 2012, Science Translational Medicine.
[75] Joshua F. McMichael,et al. The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.
[76] William Wheeler,et al. Detectable clonal mosaicism and its relationship to aging and cancer , 2012, Nature Genetics.
[77] Ingo Ruczinski,et al. Detectable clonal mosaicism from birth to old age and its relationship to cancer , 2012, Nature Genetics.
[78] Christian Bastard,et al. TET2 and DNMT3A mutations in human T-cell lymphoma. , 2012, The New England journal of medicine.
[79] J. Berg,et al. Dnmt3a is essential for hematopoietic stem cell differentiation , 2011, Nature Genetics.
[80] Chuan He,et al. Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine , 2011, Science.
[81] Yang Wang,et al. Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA , 2011, Science.
[82] K. Rajewsky,et al. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice , 2011, Proceedings of the National Academy of Sciences.
[83] O. Abdel-Wahab,et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.
[84] D. Neuberg,et al. Clinical effect of point mutations in myelodysplastic syndromes. , 2011, The New England journal of medicine.
[85] R. Medzhitov,et al. p53-mediated hematopoietic stem and progenitor cell competition. , 2010, Cell stem cell.
[86] L. Ferrucci,et al. Red blood cell distribution width and the risk of death in middle-aged and older adults. , 2009, Archives of internal medicine.
[87] Mario Cazzola,et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. , 2005, The New England journal of medicine.
[88] M. Burns,et al. Case-Control Study , 2020, Definitions.
[89] T. Kunkel. DNA Replication Fidelity* , 2004, Journal of Biological Chemistry.
[90] Irving L. Weissman,et al. Physiological Migration of Hematopoietic Stem and Progenitor Cells , 2001, Science.
[91] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[92] I. Weissman,et al. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[93] E. Li,et al. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases , 1998, Nature Genetics.
[94] A. Green,et al. Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes , 1997, British journal of haematology.
[95] G. Huez,et al. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. , 1995, Blood.
[96] D. Shibata,et al. BCL2 translocation frequency rises with age in humans. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[97] M. Fey,et al. Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe. , 1994, Blood.
[98] Jeffrey H. Miller,et al. Mutagenic deamination of cytosine residues in DNA , 1980, Nature.
[99] J. Rowley. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.